These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 27110054)

  • 41. Clinical features and prognostic analysis of lymphoma-associated hemophagocytic syndrome: A report of 139 cases.
    Zhang Q; Wang L; Zhou D; Zhu L; Li L; Xie W; Tan Y; Ye X
    Oncol Lett; 2023 Jan; 25(1):13. PubMed ID: 36478898
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical significance of serum lactate dehydrogenase, β2-microglobulin and vascular endothelial growth factor level detection in patients with non-Hodgkin's lymphoma].
    Duan Y; Li G; Hu HX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):608-10. PubMed ID: 22739165
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical Features and Prognostic Risk Prediction of Non-Hodgkin Lymphoma-Associated Hemophagocytic Syndrome.
    Yao S; Jin Z; He L; Zhang R; Liu M; Hua Z; Wang Z; Wang Y
    Front Oncol; 2021; 11():788056. PubMed ID: 34938663
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinical prognostic analysis of 124 adult patients with hemophagocytic lymphohistiocytosis: a multicenter retrospective study of the Huaihai Lymphoma Working Group].
    Shen ZY; He CL; Sun Q; Zhang S; Hu LL; Liu QH; Zhang H; Liu X; Miao YQ; Gu WY; Wang F; Wang CL; Shi YY; Wang L; Jiao J; Ye JJ; Xu LY; Yan DM; Li ZY; Jin YL; Huang SP; Xu KL; Sang W
    Zhonghua Xue Ye Xue Za Zhi; 2021 Oct; 42(10):800-806. PubMed ID: 34788918
    [No Abstract]   [Full Text] [Related]  

  • 45. Causes, clinical symptoms, and outcomes of infectious diseases associated with hemophagocytic lymphohistiocytosis in Taiwanese adults.
    Tseng YT; Sheng WH; Lin BH; Lin CW; Wang JT; Chen YC; Chang SC
    J Microbiol Immunol Infect; 2011 Jun; 44(3):191-7. PubMed ID: 21524613
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lymphoma associated hemophagocytic syndrome: A single-center retrospective study.
    Chang Y; Cui M; Fu X; Han L; Zhang L; Li L; Li X; Sun Z; Wu J; Zhang X; Li Z; Nan F; Yan J; Sheng G; Zhang M
    Oncol Lett; 2018 Jul; 16(1):1275-1284. PubMed ID: 30061947
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hemophagocytic Lymphohistiocytosis in Malignant Hematology: Uncommon but Should Not Be Forgotten?
    Roe C; Bennett J; Zhang L; Chavez J; Shah B; Sokol L; Komrokji R
    Clin Lymphoma Myeloma Leuk; 2015 Jun; 15 Suppl():S147-50. PubMed ID: 26297268
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Expression of Serum HMGB-1 in Patients with Secondary Hemo-phagocytic Lymphohistiocytosis and Its Clinical Significance].
    Wang DJ; Wang JJ; Song M; Gao X; Duan LM; Tian T; Qiu HX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):878-83. PubMed ID: 27342526
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The clinical significance of plasma PTX3 in patients with secondary hemophagocytic lymphohistiocytosis].
    Liu LL; Qiu HX; Xu J; Duan LM; Tian T; Wang JJ; Gao X; Yin GL; Huang JY; Cheng WY
    Zhonghua Nei Ke Za Zhi; 2020 Jul; 59(7):528-534. PubMed ID: 32594686
    [No Abstract]   [Full Text] [Related]  

  • 50. [The diagnostic value of flow cytometry in patients with lymphoma associated hemophagocytic syndrome].
    Zhang WL; Xu L; Zhang Q; Zhong FL; Dai J; Feng J; Sun LH; Xu HC; Xie WY; Zhang HY
    Zhonghua Nei Ke Za Zhi; 2020 Dec; 59(12):976-981. PubMed ID: 33256339
    [No Abstract]   [Full Text] [Related]  

  • 51. Serum beta2-microglobulin concentration as a novel marker to distinguish levels of risk in acute heart failure patients.
    Kawai K; Kawashima S; Miyazaki T; Tajiri E; Mori M; Kitazaki K; Shirotani T; Inatome T; Yamabe H; Hirata K; Yokoyama M
    J Cardiol; 2010 Jan; 55(1):99-107. PubMed ID: 20122555
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinical significance of serum calcium and albumin in patients with secondary hemophagocytic lymphohistiocytosis].
    Gao X; Qiu HX; Wang JJ; Song M; Duan LM; Tian T
    Zhonghua Xue Ye Xue Za Zhi; 2017 Dec; 38(12):1031-1035. PubMed ID: 29365395
    [No Abstract]   [Full Text] [Related]  

  • 53. [Diagnostic significance of glycosylated ferritin for patients with secondary hemophagocytic lymphohistiocytosis].
    Wang YN; Wang Z; Wang JS; Feng CC; Tian LP; Wu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1379-82. PubMed ID: 19099648
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The significance of pre-therapeutic F-18-FDG PET-CT in lymphoma-associated hemophagocytic lymphohistiocytosis when pathological evidence is unavailable.
    Wang J; Wang D; Zhang Q; Duan L; Tian T; Zhang X; Li J; Qiu H
    J Cancer Res Clin Oncol; 2016 Apr; 142(4):859-71. PubMed ID: 26666755
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical assessment of Mycoplasma pneumoniae-associated hemophagocytic lymphohistiocytosis.
    Yoshiyama M; Kounami S; Nakayama K; Aoyagi N; Yoshikawa N
    Pediatr Int; 2008 Aug; 50(4):432-5. PubMed ID: 18937751
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The prevalence and prognosis of hyponatraemia in non-Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis.
    Yin G; Man C; Cheng W; Gao X; Wang J; Tian T; Xu J; Duan L; Qiu H
    Leuk Lymphoma; 2022 Feb; 63(2):362-369. PubMed ID: 34661498
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical characteristics of extranodal NK/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis.
    Liu YZ; Bi LQ; Chang GL; Guo Y; Sun S
    Cancer Manag Res; 2019; 11():997-1002. PubMed ID: 30774427
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lymphoma-associated hemophagocytic syndrome: clinical features and treatment outcome.
    Han AR; Lee HR; Park BB; Hwang IG; Park S; Lee SC; Kim K; Lim HY; Ko YH; Kim SH; Kim WS
    Ann Hematol; 2007 Jul; 86(7):493-8. PubMed ID: 17347847
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Time to first disease progression, but not beta2-microglobulin, predicts outcome in myeloma patients who receive thalidomide as salvage therapy.
    Palumbo A; Bringhen S; Falco P; Cavallo F; Ambrosini MT; Avonto I; Gay F; Caravita T; Bruno B; Boccadoro M
    Cancer; 2007 Aug; 110(4):824-9. PubMed ID: 17594696
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical Efficacy of Programmed Cell Death Ligand 1 Antibody in Treatment of Extranodal Natural Killer/T-Cell Lymphoma With Hemophagocytic Lymphohistiocytosis.
    Yang CL; Chen X; Zhou HJ; Wu WC; Zou LQ
    J Hematol; 2024 Apr; 13(1-2):46-51. PubMed ID: 38644986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.